Nazila Habibizad - 01 Mar 2022 Form 3/A - Amendment Insider Report for Global Blood Therapeutics, Inc.

Role
Executive Vice President, Operations
Signature
/s/ Miguel Carrillo, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
3/A - Amendment
Filing time
03 Aug 2022, 17:45:30 UTC
Date Of Original Report
03 Mar 2022
Next filing
05 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GBT Common Stock 10,528 01 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amendment filed to correct the number of shares reported as beneficially owned by the Reporting Person on her original Form 3, which inadvertently overstated the number of shares held. The overstatement was carried forward on the Reporting Person's subsequent filed Forms 4.

Remarks:

Executive Vice President, Operations